Evidence map›Paper›PMID 41902981›Full record

ArticleMikrochimica acta2026

Chiral molecularly imprinted polymer-functionalized achiral covalent organic frameworks as stationary phases for efficient enantioseparation of tyrosine in capillary electrochromatography.

Mingxuan Ma, Yun Wu, Haijian Xia

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mingxuan MaDepartment of Pharmacy, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu Province, 225000, People's Republic of China.
Yun WuDepartment of Pharmacy, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu Province, 225000, People's Republic of China.
Haijian XiaDepartment of Pharmacy, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu Province, 225000, People's Republic of China. 315284853@qq.com.

Funding

the Basic Science (Natural Science) Research Projects in Higher Education Institutions in Jiangsu Province 22KJD350003
6 · The paper itself

Abstract

For tyrosine enantiomers it is difficult to achieve specific separations. To solve this problem, a coated capillary column was fabricated, which is based on covalent organic frameworks (COFs) modified by chiral molecularly imprinted polymers (MIPs). The design of this column takes full advantage of two core properties: the molecular recognition specificity of molecular imprinting technology, and the excellent chromatographic separation performance of COFs. In a capillary electrochromatography (CEC) system, compared to capillary columns coated solely with MIP(APTES-TEOS) or achiral COFs, the as-prepared column exhibited a remarkably enhanced enantioseparation capability for tyrosine, with an increase of the separation resolution from 1.36/0 to 4.42. Furthermore, the enantioseparation mechanism of the developed CEC system was investigated in depth via adsorption kinetic experiments, adsorption isotherm fitting, and thermodynamic analysis. The findings verified the preferential adsorption of MIP(APTES-TEOS)@TpPa-1 toward L-Tyr compared to D-Tyr. This study provides novel insights into the application of advanced nanomaterial coating strategies in CEC systems, thereby exhibiting considerable application potential within the field of chiral separation.

Indexed as

Chiral molecularly imprinted polymersCovalent organic frameworksOpen-tubular columnTyrosine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.